- Report
- April 2023
- 85 Pages
Global
From €3500EUR$4,227USD£3,142GBP
- Report
- February 2025
- 90 Pages
Brazil, China, India, ... Brazil, China, India, Russia
From €5317EUR$5,995USD£4,612GBP
- Report
- December 2024
- 32 Pages
Brazil
From €4430EUR$4,995USD£3,843GBP
- Report
- December 2024
- 30 Pages
Mexico
From €4430EUR$4,995USD£3,843GBP
- Report
- December 2024
- 31 Pages
Japan
From €4430EUR$4,995USD£3,843GBP
- Report
- December 2024
- 32 Pages
China
From €4430EUR$4,995USD£3,843GBP
- Report
- December 2024
- 30 Pages
South Korea
From €4430EUR$4,995USD£3,843GBP
- Report
- December 2024
- 31 Pages
Russia
From €4430EUR$4,995USD£3,843GBP
- Report
- December 2024
- 31 Pages
Spain
From €4430EUR$4,995USD£3,843GBP
- Report
- December 2024
- 35 Pages
Italy
From €4430EUR$4,995USD£3,843GBP
- Report
- December 2024
- 30 Pages
France
From €4430EUR$4,995USD£3,843GBP
- Report
- December 2024
- 34 Pages
United Kingdom
From €4430EUR$4,995USD£3,843GBP
- Report
- December 2024
- 47 Pages
United States
From €4430EUR$4,995USD£3,843GBP
- Report
- September 2025
- 50 Pages
Global
From €2350EUR$2,650USD£2,039GBP
- Report
- September 2025
- 50 Pages
Global
From €2350EUR$2,650USD£2,039GBP
- Report
- June 2025
Global
From €21730EUR$24,500USD£18,848GBP
- Report
- June 2025
Global
From €1641EUR$1,850USD£1,423GBP
- Report
- June 2025
Thailand
From €1641EUR$1,850USD£1,423GBP
- Report
- June 2025
Taiwan
From €1641EUR$1,850USD£1,423GBP
- Report
- June 2025
Switzerland
From €1641EUR$1,850USD£1,423GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more